<DOC>
	<DOCNO>NCT02729207</DOCNO>
	<brief_summary>The safety efficacy Esflurbiprofen Hydrogel Patch assess compare placebo treatment acute pain due ankle sprain</brief_summary>
	<brief_title>Proof-of-concept Study NSAID Hydrogel Patch Treatment Acute Pain</brief_title>
	<detailed_description />
	<mesh_term>Acute Pain</mesh_term>
	<mesh_term>Ankle Injuries</mesh_term>
	<criteria>1 . Subject must male female age 18 65 year , inclusive . 2 . Subject must diagnosis uncomplicated acute minor ankle sprain Grade I II define AAOS criterion . 3 . Ankle sprain must occur &lt; 48 hour prior Screening . 4 . Subject must baseline selfevaluated pain score &gt; 50 mm 100 mm VAS bearing weight affect ankle . 5 . Female subject childbearing potential must negative serum pregnancy test Screening willing use acceptable form birth control day first dose administration 30 day last administration study product . 6 . Subject must willing refrain use pain medication ( allow rescue medication ) participation . 1 . Subject pregnant , breastfeeding , lactate female . 2 . Subject acute ankle sprain Grade III define AAOS criterion . 3 . Subject ankle fracture confirm Xray . 4 . Ankle sprain require surgical treatment . 5 . Subject experienced recurrent sprain ( â‰¥3 sprain joint ) sprain affected joint within last 12 month . 6 . Subject take analgesic NSAID ( ) acetaminophen purpose within 7 day Screening . 7 . Subject take flurbiprofen naproxen within 24 hour Screening . 8 . Ankle sprain treat prior Screening ultrasound , physical therapy , acupuncture . 9 . Subject use immunomodulators immunosuppressive therapy ( e.g. , interferon , oral parenteral corticosteroid , cytotoxic drug ) within 4 week prior randomization . 10 . Subject use medicated topical agent ( e.g. , medicate cream lotion ) affect ankle within 7 day prior Screening . 11 . Subject currently use medication , opinion Investigator , may exacerbate mask anticipated side effect NSAIDs interfere Investigator 's ability monitor ( e.g. , blood thinner protonpump inhibitor ) . 12 . Subject nonintact damage skin area treat ( e.g. , eczema , psoriasis , exudative dermatitis , infected lesion , burn , wound ) . 13 . Subject history ulcer , GI bleeding , hypertension , edema , heart failure , CV disease . 14 . Subject asthma ( except childhood asthma ) , urticaria , angioedema , bronchospasm . a.A subject eligible study symptom condition require medication 5 year prior Screening . 15 . Subject history chronic pain disorder . 16 . Subject coagulation defect . 17 . Subject history severe cardiac , renal , hepatic impairment within 12 month prior Screening , opinion Investigator , would interfere outcome study . 18 . Subject severe systemic disease ( e.g. , cancer severe acute infection ) . 19 . Subject know allergy hypersensitivity flurbiprofen , aspirin , NSAID ( ) , excipient IP . 20 . Subject systemic dermatologic disorder , opinion Investigator , interfere study result increase risk AEs . 21 . Subject history uncontrolled chronic acute concomitant disease , Investigator 's opinion , would contraindicate study participation confound interpretation result . 22 . Subject applied ice compression affect ankle within 2 hour prior Screening . 23 . Subject bilateral ankle injury . 24 . Subject ipsilateral knee injury . In opinion Investigator , unsuitable inclusion study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>NSAID Patch</keyword>
</DOC>